SENATE-BILL 1836: S.1836 - SMART Prices Act
AI-Powered Summary
SENATE-BILL 1836 aims to amend the Social Security Act to implement significant drug pricing reforms, primarily targeting the affordability of prescription medications under Medicare. The legislation addresses major themes such as healthcare access, affordability, and the regulation of pharmaceutical pricing, particularly benefiting seniors and low-income individuals who depend on Medicare. Key provisions include increasing the number of drugs eligible for price negotiations from 15 to 50, reducing the qualification period for single-source drugs from 7 and 11 years to 3 years, and establishing maximum fair price ceilings to lower out-of-pocket costs for consumers. The bill is set to take effect in 2028, providing a timeline for implementation that may influence individuals' healthcare planning. Overall, the bill seeks to enhance access to affordable medications while navigating constitutional concerns regarding federal regulation of drug prices and the rights of pharmaceutical companies.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant implications for individual rights, particularly in the context of healthcare access and economic equity. By lowering drug prices, it seeks to alleviate financial burdens on individuals who rely on Medicare, thereby promoting public welfare.
Key Individual Rights
- Right to Health Care
- Equal Protection under the Law
Constitutional Provisions
- 14th Amendment - Equal Protection Clause
- Commerce Clause
Potential Constitutional Challenges
While the bill supports equitable access to medications, it may face challenges regarding the extent of federal power in regulating drug prices. Opponents could argue that it infringes on the rights of pharmaceutical companies and disrupts free market principles, potentially leading to claims of government overreach.
Summary
SENATE-BILL 1836 is likely to positively impact various demographic groups, particularly seniors and low-income individuals, by making essential medications more affordable. The bill aligns with constitutional principles of equality and justice, aiming to address disparities in healthcare access. However, the potential for legal challenges regarding federal regulatory power exists, which could shape the future of healthcare policy and individual rights.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 1836 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
May 21, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat